Invus

Invus discloses dealings in 2 companies, chiefly Valerio Therapeutics and Sensorion. In total, 3 filings cover trades dated from 9 June 2023 to 21 December 2023.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 1 January 2024: a transaction of €7.5M, in Valerio Therapeutics. The median gap between a trade and its publication by AMF is 11 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from AMF. Past trades are no guide to future returns.